3results about How to "Improve overall performance" patented technology

The application relates to the field of biological medicine, and discloses a bifidobacterium adolescentis YF-01 and application of the bifidobacterium adolescentis YF-01 in fermented milk. The bifidobacterium adolescentis YF-01 is isolated from adult feces and is preserved in the China Center for Type Culture Collection, with a preservation number of CCTCC NO: M 20251308. Experiments prove that the bifidobacterium adolescentis YF-01 has good gastrointestinal fluid tolerance, the survival rate can reach 90.1% after being treated by simulated gastric juice for 3 hours, and the survival rate can reach 72% after being treated by simulated intestinal juice for 4 hours. The self-aggregation rate of the strain is 88.83%, and the hydrophobicity is 79.41%; the strain has significant scavenging capacity for DPPH free radicals and hydroxyl free radicals, and shows good antioxidant activity and adhesion capacity, which provides a theoretical basis for the application of the strain in fermented milk. The strain and metabolites thereof can be used for preparing food, medicine or health care products with the functions of regulating intestinal flora and enhancing antioxidant capacity, and have significant application potential in the development of functional fermented milk products.

The present application relates to a kind of protein markers for diagnosing postmenopausal osteoporosis and its application, belong to biological medicine technical field.The present application is screened, and it is found that NADH dehydrogenase 1 beta subcomplex subunit 4, NADH dehydrogenase 1 beta subcomplex subunit 5, NADH dehydrogenase 1 beta subcomplex subunit 6, NADH dehydrogenase 1, NADH dehydrogenase 1 alpha subcomplex subunit 8, cytochrome c oxidase subunit 7C, cytochrome c oxidase subunit 5A and cytochrome c oxidase subunit 7A2 can be used alone or in combination in the diagnosis test of postmenopausal osteoporosis, to accurately evaluate the PMOP state of subject.Further, the combination of NDUB5 and NDUA8 two protein markers shows excellent diagnostic sensitivity and specificity, which is helpful for early diagnosis of PMOP, screening of high-risk population of fracture and precise prevention and treatment.

This application discloses a compound, an electroluminescent device, a method for preparing the same, and a display device. The compound comprises Ar, a coumarin group, and a linking group B for connecting Ar and the coumarin group. Ar is selected from structural units containing aryl and / or heteroaryl groups. The method for preparing the electroluminescent device includes the step of preparing a hole transport layer. In the process of preparing the hole transport layer, a hole transport material layer is first prepared, the material of which includes the compound. Then, the hole transport material layer is treated with a first illumination condition to form a cross-linked structure. Next, an upper functional film is prepared on one side of the hole transport material layer. After the upper functional film is prepared, the hole transport material layer is treated with a second illumination condition to de-crosslink the cross-linked hole transport material.